Startup develops targeted peptides for tumor imaging and therapy

04/18/2010 | Xconomy

Startup firm Avelas Biosciences plans to develop its fluorescent Activatable Cell-Penetrating Peptide technology for use in tumor imaging. The company hopes to eventually equip doctors with a way to precisely identify tumor parameters. The company also is looking to use the targeted peptides as carriers of cancer drugs that would zero in on tumors and leave healthy areas unharmed.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA